Immune modulating effects of daily supplementation of COLD-fX (a proprietary extract of North American ginseng) in healthy adults

Journal of Clinical Biochemistry and Nutrition

Volumn 39, Issue 3, 2006, Pages 162-167

  Predy, Gerry N ^a   Goel, Vinti ^b   Lovlin, Ray E ^b   Basu, Tapan K ^c  

^a Capital Health Edmonton   (Canada)

^b CV Technologies Inc   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

COLD fX; Common cold; NK cells

Indexed keywords

GINSENG EXTRACT; IMMUNOGLOBULIN A; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; COMMON COLD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GINSENG; HUMAN; IMMUNOMODULATION; INFLUENZA; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NORTH AMERICA; UPPER RESPIRATORY TRACT INFECTION;

PANAX; PANAX QUINQUEFOLIUS;

EID: 34248669836     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.39.162     Document Type: Article

References (29)

1. McElhaney, J.E., Gravenstein, S., Cole, S.K., Davidson, E., O'Neil, D., Petitjean, S., Rumble, B., and Shan, J.J.: A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J. Am. Geriatr. Soc., 52, 13-19, 2004.
2. McElhaney, J.E., Goel, V., Toane, B., Hooten, J., and Shan, J.J.: Efficacy of COLD-fX in the prevention of respiratory symptoms in community dwelling adults: a randomized, double-blind, placebo controlled trial. J. Alter. Compl. Med., 12, 153-157, 2006.
3. Predy, G.N., Goel, V., Lovlin, R., Donner, A., Stitt, L., and Basu, T.K.: Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for prevention of upper respiratory infections: a randomized controlled trial. C.M.A.J., 173(9), 1043-1048, 2005.
4. Wang, M., Guilbert, L.J., Ling, L., Li, J., Wu, Y., Xu, S., Pang, P., and Shan, J.J.: Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium). J. Pharm. Pharmacol., 53, 1515-1523, 2001.
5. Miller, S.C. and Shan, J.J.: CVT E002, 14 a proprietary extract of North American ginseng (Panax quinquefolium) enhances bone marrow and splenic natural killer (NK) cells and monocytes in leukemic mice, and variably influences other hemopoietic and immune cells. Book of abstract. The North American Research Conference on Complementary and Integrative Medicine, 2006, Edmonton, AB, Canada, May 24-27.
6. Wang, M., Guilbert, L.J., Li, J., Wu, Y., Pang, P., and Basu, T.K.: A proprietary extract from North American ginseng (Panax quinquefolium) enhances IL-2 and IFN-γ production in murine spleen cells induced by Con-A. Int. Immunopharmocol., 4(2), 311-315, 2004.
7. Almed, R. and Biron, C.A.: Immunity to viruses. In: Paul E. Fundamental Immunology. Philadelphia, PA: Raven Publishers 1999, pp 1303-1319.
8. Abbas, A.K., Murphy, K.M., and Sher, A.: Functional diversity of helper T-lymphocytes. Nature, 383, 787-93, 1996.
9. Hoft, D.F. and Eickhoff, C.S.: Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infect. Immunity, 73, 4934-4940, 2005.
10. O'Garra, A.: Cytokines induce the development of functionally heterogenous T helper cell subsets. Immunity, 8, 275-283, 1999.
11. Malaponte, G., Bevelacqua, V., Volti, G.L., Petrina, M., Nicotra, G., Sapuppo, V., Volti, S.L., Travali, S., and Mazzarino, M.C.: Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract. Pediatr. Res., 55, 666-673, 2004.
12. Pitkaranta, A., Nokso-Koivisto, J., Jantti, V., Takala, A., Kilpi, T., and Hovi, T.: Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children. J. Clin. Virol., 14, 199-205, 1999.
13. Magee, D.M., Williams, D.M., Smith, J.G., Bleicker, C.A., Grubbs, B.G., Schachter, J., and Rank, R.G.: Role of CD 8 T cells in primary Chlamydia infection. Infect. Immun., 63, 516, 1995.
14. Cohen, S., Hamrick, N., Rodriguez, M.S., Feldman, P.J., Rabin, B.S., and Manuck, S.B.: Reactivity and vulnerability to stress-associated risk for upper respiratory illness. Psychosomatic Med., 64, 302-310, 2002.
15. Chaushu, S., Yefenof, E., Becker, A., Shapira, J., Gat, H., and Chaushu, G.: A link between parotid salivary IgA level and recurrent respiratory infections in young Down's syndrome patients. Oral Microbiol. Immunol., 17, 172-176, 2002.
16. Robinson, L.E. and Field, C.J.: Dietary long chain (n-3) fatty acids facilitate immune cell activation in sedentary, but not exercise trained rats. J. Nutr., 128, 498-504, 1998.
17. Hsia, J., SzRein, M.B., Naylor, P.H., Simor, G.L., Goldstein, A.L., and Hayden, F.G.: Modulation of thymosin beta 4 levels and peripheral blood mononuclear subsets during experimental rhinovirus colds. Lymphokine Res., 8(4), 383-391, 1989.
18. + are each sufficient for protection against Chlamydia pneumonia infection through their ability to secrete IFN-γ. J. Immunol., 172, 2407-2415, 2004.
19. Hsia, J., Goldstein, A.L., Simon, G.L., Sztein, M., and Hayden, F.G.: Peripheral blood mononuclear cell IL-2, IFN-g production, cytotoxicity and antigen stimulated blastogenesis during experimental rhinovirus infection. J. Infectious Dis., 162, 591-597, 1990.
20. Wimalasundera, S.S., Katz, D.R., and Chain, B.M.: Characterization of the T cell response to human rhinovirus in children: implication for understanding the immunopathology of the common cold. J. Infectious Dis., 176, 755-759, 1997.
21. Godding, V., Sibille, Y., Massion, P.P., Delos, M., Sibille, C., Thurion, P., Giffroy, D., Langendries, A., and Vaerman, J.P.: Secretory component production by human bronchial epithelial cells is upregulated by interferon gamma. Eur. Respir. J., 11, 1043-1052, 1998.
22. Bossie, R. and Vitetta, E.S.: Interferon- gamma enhances secretion of IgG2a from IgG2a committed LPS-stimulated murine B cells: implications for the role of IFN-γ in class switching. Cell. Immunol., 135, 95-104, 1991.
23. Adachi, Y., Kindzelski, A.L., Petty, A.R., Huang, J.B., Maeda, N., Yotsumoto, S., Aratani, Y., Ohno, N., and Petty, H.R.: IFN-gamma primes RAW 264 macrophages and human monocytes for enhanced oxidant production in response to CpG DNA via metabolic signaling: roles of TLR9 and myeloperoxidase trafficking. J. Immunol., 176, 5033-5040, 2006.
24. Volti, G.L., Malaponte, G., Bevelacqua, V., Messina, A., Bianca, S., Mazzarino M.C., and Volti, S.L.: Persistent high plasma levels of interleukin 18 and 4 in children with recurrent infections of the upper respiratory tract. Transplantation Proceedings. 35, 2911-2915, 2003.
25. Sullivan, B.M., Jobe, O., Lazarevic, V., Vasquez, K., Bonson, R., Glimcher, L.H., and Kramnik, I.: Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlated with increased IL-10 and decreased IFN-γ production. J. Immunol., 175, 4593-4602, 2005.
26. Stockl, J., Vetr, H., Majdic, O., Zlabinger, G., Kuechler, E., and Knapp, W.: Human major group rhinoviruses downregulate the accessory function of monocytes by inducing IL-10. J. Clin. Invest., 104, 957-965, 1999.
27. Mazanec, M.B., Nedrud, J.G., Liang, X., and Lamm, M.E.: Transport of serum IgA into murine respiratory secretions and its implication for immunization strategies. J. Immunol., 142, 4275-4281, 1989.
28. Wright, P., Karren, R., Belshe, R., Thompson, J., Crowe, J., Boyce, T., Halburnt, L., Reed, G., Whitehead, S., Anderson, E., Wittek, A., Casey, R., Eichelberger, M., Thumar, B., Randolph, V., Udem, S., Chanock, R., and Murphy, B.: Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J. Infectious Dis., 182, 1331-1342, 2000.
29. Kawase, T., Kusugami, K., Matsunaga, H., Matsura, T., and Morisi, K.: Impaired regulation of natural killer cells in immunoglobulin synthesis by peripheral blood mononuclear cells from patients with ulcerative colitis. Gastroenterol. Jpn., 25(5), 585-592, 1990.